The Most Clinically Validated Vitamin K2 as MK7
MenaQ7® Matrix75µg
What Is Vitamin K2 Good For?
Calcium is vital for bone building and strengthening, however you need to ensure calcium is not deposited in the arteries, where it can build up and cause serious cardiovascular risk. MenaQ7® Matrix, found in the LYMA Supplement, regulates calcium balance.
Why Do We Need Calcium?
Our bodies need calcium to maintain strong bones, the heart, muscles and nervous system also need calcium to function properly.
Why Choose a Natural K2?
Fermentation by microorganisms represents the natural process of producing vitamin K2 in its most bioactive, all-trans form. By mimicking nature, natural vitamin K2 undergoes production untainted by additives or chemical interference, ensuring a clean-label process.
Why Do Our Scientists Prefer MenaQ7® Matrix?
MenaQ7® Matrix is designed to be stable in formulations containing other ingredients. This ensures vitamin K2’s stability and shelf-life, even in complex formulations, to ensure its efficacy.
How Much Vitamin K2 Should I Take Per Day?
Peer reviewed studies point to an optimal dose of 75μg per day. This is the dose that we include in The LYMA Supplement formula.
Calcium build up in the arteries can cause serious cardiovascular risk, as well as bones, our heart, muscles and nervous system need calcium. Synthetic K2 is considered more effective than natural. There is an important link between Vitamin K and Vitamin D.
MenaQ7® Matrix in Detail
75μg
Vitamin K2 Mk7
Derived by natural fermentation, MenaQ7® Matrix comesin the most bioactive form of vitamin K2, as all-trans MK-7 isomers
10x standard Vitamin K2
The clinically proven benefits of MenaQ7® are delivered with the very latest in vitamin K2 protection, with an innovative clean-label technology. With MenaQ7® Matrix, vitamin K2 stability and efficacy is ensured – even in the most complex formulations
Europe
22 peer-reviewed MenaQ7® clinical trials
Your Questions About MenaQ7® Matrix And Vitamin K2
Though vitamin K is present in many foods, vitamin K2 can only be found in animal sourced foods and fermented plant foods. Chicken, pork chops, beef liver, and many organ meats all have high levels of vitamin K2. Soybeans, sauerkraut, and cheese are also rich in vitamin K2. The LYMA Supplement contains the proven clinical dose in 4 pills a day, along with 9 other key nutraceuticals.
Vitamin K2 deficiency symptoms can manifest as improper clotting or increased bleeding, including bruising easily, small blood clots under the fingernails, nose bleeds, and blood in stools.
Supplementing with vitamin K2 is generally considered very safe and does not interfere with normal blood clotting function, however it is not recommended for those with high blood pressure. You should always consult your medical practitioner before taking any new supplement, including vitamin K2, alongside any other medication.
Vitamins D3 and K2 have been widely credited with supporting weight loss as they optimise the body's metabolism by promoting healthy thyroid function, supporting glucose breakdown, and helping to balance insulin resistance.
Not only does vitamin K2 increase the skin’s healing capacity but it also supports its natural barrier function. In addition to this, by directing calcium to the most deserving areas of the body, vitamin K2 inadvertently boosts skin health. By lessening the calcification of elastin within the skin, both collagen and elastin are preserved for a more youthful appearance.
For maximum health benefits, Vitamin K2 should be taken alongside vitamin D3, ideally in a combined supplement and close to a meal.
References
1. Effect of menaquinone-7 (vitamin K2) on vascular elasticity in healthy subjects: results from a one-year study: https://www.researchgate.net/publication/343425811_Effect_of_Menaquinone-7_vitamin_K2_on_vascular_elasticity_in_healthy_subjects_results_from_a_one-year_study
2. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients – a single-arm, single-center
clinical trial: https://pubmed.ncbi.nlm.nih.gov/28756183/
3. High dephosphorylated-uncarboxylated MGP in haemodialysis patients: risk factors and response to vitamin K2, a pre-post intervention clinical trial: https://pubmed.ncbi.nlm.nih.gov/28592319/
4. Steady-state vitamin K2 (menaquinone-7) plasma concentrations after intake of dairy products and soft gel capsules: https://pubmed.ncbi.nlm.nih.gov/26908424/
5. Yogurt drink fortified with menaquinone-7 improves vitamin K status in a healthy population: https://pubmed.ncbi.nlm.nih.gov/26495126/
6. Effectof vitamin K2 on progression of atherosclerosis and vascular calcification in
nondialysed patients with chronic kidney disease stages 3-5: https://pubmed.ncbi.nlm.nih.gov/26176325/
7. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial: https://pubmed.ncbi.nlm.nih.gov/25694037/
8. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects: https://pubmed.ncbi.nlm.nih.gov/22289649/
9. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein: https://pubmed.ncbi.nlm.nih.gov/23062766/
10. Three year low dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women: https://pubmed.ncbi.nlm.nih.gov/23525894/
11. The efficacy of vitamin K2 and calcitriol combination on thalassemic osteopathy: https://pubmed.ncbi.nlm.nih.gov/24136015/
12. The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children: https://pubmed.ncbi.nlm.nih.gov/19450370/
13. VitaminK2 supplementation in haemodialysis patients: a randomised dose-finding study: https://academic.oup.com/ndt/article/29/7/1385/1842871?login=false
14. Effect of vitamin K2 supplementation on functional vitamin K deficiency in haemodialysis patients: a randomised trial: https://pubmed.ncbi.nlm.nih.gov/22169620/
15. Vitamin K status in healthy volunteers: https://pubmed.ncbi.nlm.nih.gov/24296867/
16. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women: https://pubmed.ncbi.nlm.nih.gov/23140417/